1. Home
  2. WLY vs TMDX Comparison

WLY vs TMDX Comparison

Compare WLY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

HOLD

Current Price

$47.51

Market Cap

2.1B

ML Signal

HOLD

TMDX

TransMedics Group Inc.

HOLD

Current Price

$66.95

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLY
TMDX
Founded
1807
1998
Country
United States
United States
Employees
5200
N/A
Industry
Books
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WLY
TMDX
Price
$47.51
$66.95
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$148.22
AVG Volume (30 Days)
488.3K
1.0M
Earning Date
06-16-2026
05-05-2026
Dividend Yield
3.50%
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.20
Revenue
N/A
$605,494,000.00
Revenue This Year
$1.04
$24.25
Revenue Next Year
$2.36
$18.75
P/E Ratio
$15.84
$388.75
Revenue Growth
N/A
37.13
52 Week Low
$28.38
$60.11
52 Week High
$48.19
$156.00

Technical Indicators

Market Signals
Indicator
WLY
TMDX
Relative Strength Index (RSI) 65.70 39.81
Support Level $39.68 $64.90
Resistance Level $48.19 $71.14
Average True Range (ATR) 2.01 4.26
MACD 0.07 0.65
Stochastic Oscillator 88.93 7.70

Price Performance

Historical Comparison
WLY
TMDX

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: